Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
39
Number of overlapping holdings
33.1%
% of XBI's 119 holdings also in SBIO
45.9%
% of SBIO's 90 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
ALKERMES PLC | 1.0% | 4.1% | 1.0% |
 |
AVIDITY BIOSCIENCES INC | 1.0% | 3.1% | 1.0% |
|
RHYTHM PHARMACEUTICALS, INC. | 0.9% | 3.8% | 0.9% |
|
CRINETICS PHARMACEUTICALS INC | 0.8% | 2.7% | 0.8% |
|
ACADIA PHARMACEUTICALS INC | 0.8% | 2.3% | 0.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to SBIO
|
NATERA INC | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
|
INSMED INC | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.6% |
|
GILEAD SCIENCES INC | 2.5% |
|
EXACT SCIENCES CORP | 2.5% |
|
AMGEN INC | 2.5% |
|
INCYTE CORP | 2.4% |
XBI Underweight Relative to SBIO
|
AXSOME THERAPEUTICS, INC. | -4.4% |
|
ALKERMES PLC | -3.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.9% |
 |
MERUS N.V. | -2.9% |
|
PTC THERAPEUTICS INC | -2.9% |
|
RHYTHM PHARMACEUTICALS, INC. | -2.8% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.4% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.3% |
|
AKERO THERAPEUTICS, INC. | -2.2% |
|
AVIDITY BIOSCIENCES INC | -2.1% |